Project Grant R34NS132808

Award Date 9/15/23
Completion Date 8/31/25
Dollars Obligated $646K
Federal Grant Program
93.372
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
The Regents of the University of Michigan received a $137,586 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant funds the development of a reconfigurable neural interface platform that can integrate multiple sensor modalities, including electrophysiological recording, neurostimulation, and physiochemical...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is for the development and validation of micro-LED optoelectrode platforms to enable high-density, artifact-free neural modulation and recording in behaving animal models. The $556,525 award, effective June 1, 2025 through April 30, 2030, will support the Regents of the University of...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,988,947 to the Regents of the University of Michigan to develop a scalable high-plex pipeline for whole-brain proteomics profiling. The goal is to create a 100-plex antibody panel and novel ultra-speed light-sheet microscope and data management system to generate comprehensive proteomic atlases of the whole mouse brain across 6 postnatal...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke awarded a $3,045,502 Project Grant to the Regents of the University of Michigan on August 18, 2022 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The grant funds the development of optical neural motes to enable high-density neural recording through intact dura in nonhuman primates. Specifically, the University of Michigan will design...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $431,750.00 to develop a new whole-brain PET-based molecular neuroimaging technique for non-invasively mapping neuronal circuit activity in awake mammals. The goal is to create a tool that can identify neuronal circuits involved in complex behaviors and cognitive tasks, which can...
The University of Chicago received a $3.89 million Project Grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke under the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program. The grant will fund research from August 2022 through August 2025 to directly measure and manipulate the spiking activity of locus coeruleus and ventral tegmental area axons in the hippocampus of mice during hippocampal-dependent...
The University of Michigan received a $130,230 Project Grant award under the National Institute of Neurological Disorders and Stroke's (NINDS) Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The award will fund the Neuroscience Undergraduate Research Opportunities (NURO) program, which aims to prepare undergraduates for long-term careers in basic or clinical neuroscience research. Key program components include hands-on research experience,...
The National Institute of Mental Health (NIMH) awarded a $2,515,724 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Regents of the University of Michigan to further develop NTracer2, a cloud-based platform for brain image visualization and neuron tracing. The project aims to establish NTracer2's SISF data framework as a scalable image data standard, continue developing the NTracer2 content delivery network and application server, and deploy the full-stack...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a $2,554,313 federal Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant, which runs from Sep 1, 2023 to Aug 31, 2026, will support research to determine if targeted in vivo manipulations of local circuit control...
The National Institutes of Health (NIH) Office of the Director awarded a $1,345,424 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Regents of the University of Michigan. The grant, effective September 10, 2024 through September 9, 2027, aims to develop a novel genetically encoded "protein ticker tape" system that enables long-term, brain-wide recording of single-cell physiology in live mice without external interfacing. The technology will leverage...

The Regents of the University of Michigan was awarded a $646,000 project grant from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The funding will support research to identify the neural processes within the paraventricular nucleus of the thalamus (PVT) that underlie individual variation in cue-motivated behavior. Using fluorescence-based calcium imaging and machine learning, the project aims to characterize the "neural signature" of the PVT that predicts subsequent cue-motivated behavior. Additionally, the research will stimulate the top-down input from the prelimbic cortex to the PVT using chemogenetics, and assess the resulting neuronal activity and brain-behavior relationship. The goal is to generate a pipeline for future studies to further probe the neural circuits by which environmental stimuli gain control over behavior. The project period runs from September 15, 2023 to August 31, 2025.

Generated 8/13/24, 7:09 AM